RePORT International Resources

The Young Investigators Network focuses on funding and support in basic research on HIV/AIDS, viral hepatitis, STI, TB and emerging infectious diseases. This page posts various upcomomg opportunities.

The Association of Public Health Labs and the US Centers for Disease Control and Prevention partner to offer paid laboratory internships to train and prepare college students for careers at public health laboratories. Interns join public health laboratory teams to make an impact on protecting the health of our communities. Interns assist laboratory professionals working on meaningful projects, including infectious diseases.

ASSOCIATION OF PUBLIC HEALTH LABORATORIES (APHL), in collaboration with the US Centers for Disease Control and Prevention, has developed a series of free, interactive modules called Essentials for the Mycobacteriology Laboratory: Promoting Quality Practices to promote competency, quality and safety in common mycobacteriology testing practices.

Provides live online courses and in-person training workshops for development covering Proposal Writing, Grant Management, Project Management, and Monitoring & Evaluation.

NOTE: This is a yearly prize. The 2025 submission period is over. The 2026 period will open in February 2026. The ASU-Science Prize for Transformational Impact recognizes the importance of innovative, use-inspired research, intentionally designed to address pressing problems. This prize recognizes transformational research that uses innovative methods and approaches to identify problems and develop solutions with impacts on policy and decision-making. The research should be designed, executed, and communicated with explicit consideration for the problem(s) and how the research contributes to a solution outcome. Such work considers the values and interests of different communities, typically with attention to ethical, economic, political, or legal contexts. The research is often collaborative, drawing on multiple disciplines, driven by desired outcomes, and considering implications for policy and decision-making. Examples could include research that addresses human and environmental health, improves education and social outcomes, or evaluates beneficial use of synthetic biology and artificial intelligence technologies. Grand Prize Winner Receives: Each year, the grand prize winner will receive a prize of US$30,000. The grand prize-winning essay will be published in Science in print and online nd receive a 5-year digital subscription to Science.

Deadline for Submissions: November 1, 2025 The Prize aims to recognize researchers who have developed innovative advances with translational potential to impact women’s health globally. Contributions within any area of women’s health* will be considered. These may cover work in areas of female-specific conditions including maternal health and chronic gynecological diseases, reproductive health including contraception and infertility affecting all persons, or elucidation of sex- and gender-specific approaches to conditions that affect women differently or disproportionately. We encourage researchers who may have made significant advances in addressing questions in these fields at the intersection of translational research and clinical applications, or who are developing new drugs, diagnostic approaches, medical devices, or healthcare technologies, to apply. Researchers who have advanced development of new solutions that can be readily deployed in low- and middle-income countries are encouraged to apply. The Prize is awarded for outstanding research performed by the applicant and as described in a 1,000-word essay.

BWF’s financial support is channeled primarily through competitive peer-reviewed award programs. BWF makes grants primarily to degree-granting institutions on behalf of individual researchers. To complement these competitive award programs, BWF also makes grants to nonprofit organizations conducting activities intended to improve the general environment for science. Please refer to the website for upcoming funding deadlines.

The Career Award for Medical Scientists provides $700,000 awarded over five years for physician-scientists to bridge advanced postdoctoral/fellowship training and the early years of faculty service.

Application Deadline: 7 October 2025 The Career Awards for Medical Scientists (CAMS) is a highly competitive program that provides $700,000 awards over five years for physician-scientists, who are committed to an academic career, to bridge advanced postdoctoral/fellowship training and the early years of faculty service. Please refer to the website for eligibility and details.

Project End Date: 30 June, 2026 This training program provides strong training in interdisciplinary research, reproducibility methods, and the responsible conduct of research while supporting students in their professional and career development. Our training objectives are: A) to appoint four new and reappoint four current trainees with varied academic backgrounds per year to a program that integrates rigorous theoretical statistical training with research experience in bioinformatics, genetics, observational studies and clinical trials, as well as additional training in biology and in reproducible, responsible and ethical conduct of research; B) to achieve a > 90% graduation rate within 5-6 years from the start of the PhD program among trainees; C) to maintain a program that produces biostatisticians trained in both standard biostatistical methods and emerging methodologies in biomedical research but also with applied research experience in an interdisciplinary working environment; D) to prepare biostatisticians who graduate from the program for competitive careers in academia, industry, and government via a curriculum that includes opportunities for a strong record of scientific publications, presentations at conferences, and experience in interdisciplinary collaborations, and teaching.

BIO Ventures for Global Health (BVGH) hosts a 10-session digital lecture series focused on essential grant writing concepts and tailored to meet the needs of clinicians and researchers in low- and middle-income countries (LMICs). The series runs through February 2024.

DEADLINE: 24 October, 2025 The Office of Disease Prevention Early Stage Investigator Lecture (ODP ESIL) award recognizes early career scientists who have made significant research contributions in prevention but who have not yet been awarded an R01 or R01-equivalent NIH research grant. In addition to meeting NIH's definition of an early stage investigator as of the nomination deadline, nominees should have: Innovative and significant research accomplishments in applied prevention research in humans, in areas that are relevant to ODP's mission Evidence of highly collaborative research projects, especially those that bridge disciplines to offer new approaches and ways of thinking in prevention research ODP is particularly interested in nominees conducting applied preventive intervention research to address common risk and protective factors for illness, injury, and the leading causes of death in the United States.

Submission Status: OPEN Submission Deadline: ONGOING Journal of Clinical Microbiology® (JCM) welcomes contributions to a Special Series on Diagnostic Testing for Mycobacteria. Tuberculosis is currently the world’s top infectious killer, and non-tuberculous mycobacteria (NTM) infections are also on the rise. Mycobacterial infections are more common in low-income nations and in patients with chronic health conditions. Accessible and accurate diagnosis of these infections is needed to guide effective treatment in these vulnerable patients. What We’re Looking for We welcome studies about the following: Inexpensive and accurate tests for tuberculosis, particularly tests that reduce the barriers of sputum-based diagnostics. Novel whole genome sequencing approaches to improve care of patients with tuberculosis through prediction of antimicrobial susceptibility and to improve rapid investigation of the spread of M. tuberculosis. Novel methods for rapid diagnostic testing for non-tuberculosis mycobacteria and for detection of antimicrobial resistance in mycobacteria (including non-tuberculosis and rapid-growing mycobacteria). Improved and novel diagnostics, including non-invasive tests, for extra-pulmonary tuberculosis. Suggested article types: Full-Length Text* New-Data Letter* Minireview** Commentary**

This Notice of Funding Opportunity (NOFO) will provide the early stage translational support needed for prototype testing/design modification, assay development for diagnostic disease targets, and development of research tools for use in the treatment of heart, lung, blood, and sleep (HLBS) diseases and disorders. This NOFO is part of a suite of Catalyze innovation grants to advance projects to the point where they can meet the entry criteria for the NHLBI Catalyze Preclinical program or attract independent development support from other federal or private partners for preclinical product optimization and characterization. Please refer to the website for detail announcement and key dates.

This CDC resource provides up-to-date surveillance data and statistics on tuberculosis (TB) in the United States.

A library of resources for the prevention, management, and elimination of TB.

Mantoux Tuberculin Skin Test Video

NEEMA supports development of a variety of web- and spreadsheet-based tools designed to provide state health policy makers and practitioners with information on local population sizes, disease trends, and cost projects for a variety of prevention strategies related to TB and other diseases.

CDC has developed multiple tools for use in management and analysis of data collected during TB contact, cluster, and outbreak investigations.

The Translating Research into Practice (TRiP) Workgroup was formed in 2006 by the Tuberculosis Epidemiologic Studies Consortium (TBESC) to promote application and dissemination of TBESC research findings to field and public health practice. This website gives public health partners access to select tools and products from TBESC studies.